Spartan Planning & Wealth Management Neogenomics Inc Transaction History
Spartan Planning & Wealth Management
- $89.6 Million
- Q4 2023
A detailed history of Spartan Planning & Wealth Management transactions in Neogenomics Inc stock. As of the latest transaction made, Spartan Planning & Wealth Management holds 92 shares of NEO stock, worth $1,653. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92
Previous 92
-0.0%
Holding current value
$1,653
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
295Shares Held
125MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$353 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$252 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$124 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$119 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$118 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.26B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...